Article
Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy
2022-03-09
Abstract excerpt
<h4>Background: </h4> Long-standing inflammatory bowel disease predisposes to the development of colorectal cancer (CRC). Interleukin (IL) -6, a pivotal link between chronic inflammation and tumor progression, has recently been recognized as a potential target. The effect of IL-6 on proliferation and metastasis of CRC by activating STAT3 pathway has been widely demonstrated in recent years, but few on mediating tu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e88efb3-e16f-5c77-929f-bdb402d5f515
- DOI
- 10.21203/rs.3.rs-1420368/v1
